Pyrazinamide PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Pyrazinamide PCD pharma franchise company in India, offering a focused range of 4 Pyrazinamide formulations manufactured at WHO-GMP certified facilities. We supply consistent, DCGI-approved anti-tubercular products to franchise partners and distributors who need dependable stock and district-wise monopoly support.
What is Pyrazinamide?
Pyrazinamide is a first-line anti-tuberculosis agent and a nicotinamide analogue that is converted to active pyrazinoic acid inside the tuberculosis bacillus. It is used only in combination with other anti-TB drugs during the intensive phase of therapy. Learn more from the PubChem compound record.
Available Pyrazinamide Formulations
Our current Pyrazinamide portfolio spans 4 Pyrazinamide formulations available in the following forms: Tablets. Every batch is quality tested and released under WHO-GMP controls to ensure uniform quality across supply cycles.
Therapeutic Applications
Pyrazinamide is indicated for combination treatment of pulmonary and extrapulmonary tuberculosis. It is prescribed by pulmonologists, chest and TB physicians, and infectious disease specialists and is dispensed strictly on prescription under qualified medical supervision.
Why Pyrazinamide is a High-Potential Molecule for Distributors
Tuberculosis remains a high-burden disease across India and pyrazinamide is a fixed component of standard short-course regimens, creating steady programme-driven demand that is largely insulated from seasonal swings.
Why Choose Cafoli Lifecare
Partners receive district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs, and the backing of a network of 1000+ franchise partners across India. Our supply reliability and compliance-first approach help you build a durable Pyrazinamide franchise business.
References
- PubChem: Pyrazinamide
- MedlinePlus: Pyrazinamide
- PubMed: Pyrazinamide research
Our formulations of Pyrazinamide find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: